We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-10.7%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$11.7B
AUM Growth
-$3.17B
Cap. Flow
-$1.15B
Cap. Flow %
-9.88%
Top 10 Hldgs %
46.25%
Holding
136
New
17
Increased
36
Reduced
23
Closed
34

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$440M
2
IQV icon
IQVIA
IQV
+$269M
3
AGN
Allergan plc
AGN
+$247M
4
GD icon
General Dynamics
GD
+$183M
5
FIS icon
Fidelity National Information Services
FIS
+$158M

Top Sells

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$793M
2
MDCO
Medicines Co
MDCO
+$282M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$236M
4
SPGI icon
S&P Global
SPGI
+$175M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 51.69%
2 Communication Services 12.39%
3 Technology 10.92%
4 Industrials 5.44%
5 Financials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRMR icon
101
Larimar Therapeutics
LRMR
$432M
– –
-150,697
Closed -$2.01M
OPK icon
102
Opko Health
OPK
$1.02B
– –
-2,500,000
Closed -$3.67M
PTCT icon
103
PTC Therapeutics
PTCT
$6.12B
– –
-726,986
Closed -$34.9M
RCKT icon
104
Rocket Pharmaceuticals
RCKT
$394M
– –
-354,082
Closed -$8.06M
SMH icon
105
PUT
VanEck Semiconductor ETF
SMH
$71.8B
– –
-5,010,000
Closed -$354M
SPGI icon
106
S&P Global
SPGI
$120B
– –
-640,382
Closed -$175M
SRPT icon
107
CALL
Sarepta Therapeutics
SRPT
$1.77B
– –
-400,000
Closed -$51.6M
XGN icon
108
Exagen
XGN
$166M
– –
-577,699
Closed -$14.7M
RETA
109
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-75,000
Closed -$15.3M
APTX
110
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-408,549
Closed -$1.4M
OYST
111
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-230,800
Closed -$5.64M
CCXI
112
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-1,500,000
Closed -$59.3M
GBT
113
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-750,000
Closed -$59.6M
TIF
114
DELISTED
Tiffany & Co.
TIF
– –
-225,000
Closed -$30.1M
LVGO
115
DELISTED
Livongo Health, Inc. Common Stock
LVGO
– –
-600,000
Closed -$15M
LOGM
116
DELISTED
LogMein, Inc.
LOGM
– –
-130,241
Closed -$11.2M
AXE
117
DELISTED
Anixter International Inc
AXE
– –
-917,893
Closed -$84.5M
MLNX
118
DELISTED
Mellanox Technologies, Ltd.
MLNX
– –
-270,000
Closed -$31.6M
S
119
DELISTED
Sprint Corporation
S
– –
-3,200,000
Closed -$16.7M
INST
120
DELISTED
Instructure, Inc.
INST
– –
-620,000
Closed -$29.9M
ZAYO
121
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-6,820,000
Closed -$236M
WCG
122
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-2,400,000
Closed -$793M
ARQL
123
DELISTED
Arqule Inc
ARQL
– –
-2,520,000
Closed -$50.3M
BOLD
124
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-1,190,000
Closed -$71.2M
MDCO
125
DELISTED
Medicines Co
MDCO
– –
-3,315,000
Closed -$282M
2 3 4
5
6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Farallon Capital Management held 136 positions worth $11.7B, down 21% from $14.8B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Farallon Capital Management withdrew a net $1.15B in Q1 2020, closing 34 positions and reducing 23 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $793M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 38% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Farallon Capital Management opened a new position in Centene worth $431M.

  • Farallon Capital Management's largest Q1 2020 buy was Centene: 7,250,000 shares worth $431M.
  • Farallon Capital Management added most to IQVIA in Q1 2020, an estimated $269M increase.
  • Farallon Capital Management's biggest Q1 2020 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $104M.
  • Farallon Capital Management fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $793M.
  • Farallon Capital Management's ten largest holdings make up 46% of its $11.7B portfolio in Q1 2020.
  • Farallon Capital Management opened 17 new positions and closed 34 in Q1 2020.
  • Farallon Capital Management's portfolio value fell 21% quarter-over-quarter to $11.7B.

Based on Farallon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.